{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:43:30Z","timestamp":1761871410717,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.clml.2019.09.611","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T12:37:42Z","timestamp":1575895062000},"page":"252-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["PET\/CT in Disease Detection and Follow-up of Subcutaneous Involvement in Marginal Zone Lymphoma"],"prefix":"10.1016","volume":"20","author":[{"given":"Tima","family":"Davidson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Avigdor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakov","family":"Oksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Zlotnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bar","family":"Chikman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnatan","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elinor","family":"Goshen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Ben-Haim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohad","family":"Benjamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.09.611_bib1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A\u00a0revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.611_bib2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A\u00a0clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.611_bib3","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","article-title":"Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"17","author":"Nathwani","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bjh.12730","article-title":"Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site","volume":"165","author":"Khalil","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.09.611_bib5","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.611_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.611_bib7","doi-asserted-by":"crossref","first-page":"e18534","DOI":"10.1200\/jco.2011.29.15_suppl.e18534","article-title":"Clinical features of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue","volume":"29","author":"Yamamoto","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fmed.2018.00102","article-title":"Lymphoma and lymphomagenesis in primary Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Alunno","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clml.2019.09.611_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beha.2016.07.006","article-title":"Marginal zone lymphoma: associated autoimmunity and auto-immune disorders","volume":"30","author":"Teixeira Mendes","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clml.2019.09.611_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","article-title":"Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type","volume":"24","author":"Thieblemont","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.clml.2019.09.611_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/asheducation-2005.1.307","article-title":"Clinical presentation and management of marginal zone lymphomas","author":"Thieblemont","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2019.09.611_bib12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","article-title":"A\u00a0MALT lymphoma prognostic index","volume":"130","author":"Thieblemont","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.09.611_bib13","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.09.611_bib14","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","article-title":"Role of functional imaging in the management of lymphoma","volume":"29","author":"Cheson","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5","article-title":"2-(Fluorine-18)fluoro-2-deoxy-d-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial","volume":"91","author":"Buchmann","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.09.611_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1011169332265","article-title":"Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin\u2019s lymphoma (NHL)","volume":"12","author":"Jerusalem","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdi093","article-title":"FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases","volume":"16","author":"Beal","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/annonc\/mdl295","article-title":"18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference","volume":"17","author":"Hoffmann","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib19","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hon.2578","article-title":"FDG PET\/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma","volume":"37","author":"Vaxman","year":"2019","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib21","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00261-016-0800-1","article-title":"18F-FDG PET\/CT and primary hepatic MALT: a case series","volume":"41","author":"Albano","year":"2016","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.clml.2019.09.611_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hon.2376","article-title":"Role of fluorine-18-fluorodeoxyglucose positron emission tomography\/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: a case series","volume":"35","author":"Albano","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib23","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3109\/10428194.2015.1030640","article-title":"18F-Fluorodeoxyglucose (FDG)-positron emission tomography\/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement","volume":"56","author":"Park","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.09.611_bib24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/RCT.0b013e318227a661","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and 18F fluorodeoxyglucose-positron emission tomography\/computed tomography imaging findings and follow-up","volume":"35","author":"Zhang","year":"2011","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.clml.2019.09.611_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.2152","article-title":"Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis","volume":"33","author":"Treglia","year":"2015","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2019.09.611_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cncr.21967","article-title":"Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas","volume":"107","author":"Karam","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2019.09.611_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000070290","article-title":"18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma","volume":"64","author":"Hoffmann","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.clml.2019.09.611_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0609.2007.00895.x","article-title":"Diagnostic accuracy of PET\/CT in patients with extranodal marginal zone MALT lymphoma","volume":"79","author":"Perry","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2019.09.611_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00259-016-3518-y","article-title":"18F-FDG PET\/CT in gastric MALT lymphoma: a bicentric experience","volume":"44","author":"Albano","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clml.2019.09.611_bib30","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1080\/10428194.2017.1298754","article-title":"18F-FDG PET\/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation","volume":"58","author":"Albano","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.09.611_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MNM.0000000000000614","article-title":"The role of 18F-FDG PET and PET\/CT in the evaluation of primary cutaneous lymphoma","volume":"38","author":"Qiu","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.clml.2019.09.611_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3324\/haematol.2011.057422","article-title":"Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma","volume":"97","author":"Jonak","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2019.09.611_bib33","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2006.06.0723","article-title":"Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience","volume":"24","author":"Raderer","year":"2006","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019319986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019319986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:07Z","timestamp":1761870847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265019319986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2152265019319986"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.09.611","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/CT in Disease Detection and Follow-up of Subcutaneous Involvement in Marginal Zone Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.09.611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}